Indications
Ménière disease; For the treatment of vertigo, tinnitus, hearing loss, and nausea associated with Meniere's disease.
Dosage
Initially, 8-16 mg tid. Maintenance: 24-48 mg daily in divided doses. Adjust doses according to patient needs.
Administration
May be taken with or without food.
Contraindications
Phaeochromocytoma, active or history of peptic ulcer.
Special Precautions
Patient with bronchial asthma, CV disease, urticaria, rashes, allergic rhinitis. Patient taking antihistamines. Hepatic impairment. Pregnancy and lactation.
Storage
Store between 15-30°C. Protect from moisture and light.
MedsGo Class
Antivertigo Drugs
Features
Brand
Betzine
GTIN
8906045605014
Full Details
Dosage Strength
8 mg
Drug Ingredients
- Betahistine
Drug Packaging
Tablet 1's
Generic Name
Betahistine Hcl
Dosage Form
Tablet
Registration Number
DRP-8630
Drug Classification
Prescription Drug (RX)